We are live on ! Find out more
DRUG icon

Bright Minds Biosciences
DRUG

10 hedge funds and large institutions have $399K invested in Bright Minds Biosciences in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

324% more capital inflows, than outflows

Capital inflows: $93.2K | Capital outflows: $22K

0.61% more ownership

Funds ownership: 3.5% → 4.11% (+0.61%)

9% less funds holding

Funds holding: 11 → 10 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AdvisorShares Investments
AdvisorShares Investments
Maryland
+$87.7K
2
UBS Group
UBS Group
Switzerland
+$4.05K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.42K

Top Sellers

Rank Fund Capital Flow
1
Virtu Financial
Virtu Financial
New York
-$22K

DRUG Hedge Fund Activity: Q2 2022 in Review

10 of the 5,963 institutional investors tracked by Wall St. Rank reported a position in Bright Minds Biosciences (DRUG) for Q2 2022, worth a combined $399K — down 36% from $628K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DRUG and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 3 added.

The largest buyer was AdvisorShares Investments, adding an estimated $87.7K. The largest seller was Virtu Financial, exiting entirely with an estimated $22K sold.

  • 10 institutional investors held Bright Minds Biosciences (DRUG) as of Q2 2022, down from 11 in Q1 2022.
  • Funds reported $399K of Bright Minds Biosciences stock for Q2 2022, down 36% quarter-over-quarter.
  • 0 funds opened new Bright Minds Biosciences positions in Q2 2022 and 1 closed out, a net change of -1 holder.
  • The largest Bright Minds Biosciences buyer in Q2 2022 was AdvisorShares Investments, an estimated $87.7K added.
  • The largest Bright Minds Biosciences seller in Q2 2022 was Virtu Financial, an estimated $22K sold.

Based on aggregated 13F filings for Q2 2022.